Search by...
-
26AprItalian Data Protection Authority publishes rules for platforms (websites or apps) connecting patients and healthcare professionalsIn recent years, technology has revolutionized many sectors, including healthcare. Online platforms and apps that connect patients with healthcare professionals have made medical care more accessible, especially in settings where physical presence is limited or not possible. This evolution has also raised important issues concerning privacy and the protection of personal data.
-
17AprPortolano Cavallo annuncia la nomina a partner di Alessandro TannoCon la nomina di Alessandro Tanno, il numero di soci sale a 21
-
9AprChatbots and virtual assistants: How might they be used in pharmaceuticals?Anche il settore farmaceutico si trova a fare i conti con l’avvento di chatbot e assistenti virtuali più o meno sofisticati in grado di interagire efficacemente con gli utenti. A fronte dei diversi paletti normativi, molte sono anche le opportunità per il miglioramento e la personalizzazione dell’assistenza ai pazienti
-
9Apr“Pharmacy of Services”: Simplification Decree expands the range of healthcare and telemedicine services pharmacies can provideThe new draft of the Simplification Decree, recently approved by the Council of Ministers, significantly expands the range of services that can be provided by pharmacies as part of the National Health Service.
-
25MarBest Workplaces Italia 2024: Portolano Cavallo ranks as one of the best workplaces in Italy for the eighth year in a row and is the only law firm to make the gradeFor the eighth year in a row, Portolano Cavallo was named one of the Best Workplaces™ Italia 2024 by Great Place to Work® Italia. With this recognition, the firm was again ranked one of the best places to work in Italy in its category (companies employing 50 to 149 people), and this year it earned the distinction of being the only Italian law firm on the list.
-
20MarOnline sale of medicines without a prescription: The Court of Justice of the European Union approves intermediary sitesIn its February 29, 2024 ruling, the Court of Justice of the European Union intervened on a major issue for the online medicine sales industry, opening the door for the entry of intermediary platforms.
-
6MarInfluencer del farmaco: più attenzione su profili e diffusione di contenuti alla luce delle nuove linee guida AGCOMIl fenomeno degli influencer o testimonial si sta diffondendo sempre di più anche nel mondo pharma, tanto che è stato recentemente coniato il termine di “Pharma Influencer” per indicare un professionista del settore farmaceutico che utilizza i social media e gli strumenti di comunicazione digitali per condividere contenuti relativi alla salute.
-
11JanDoctors and the use of social media and electronic communication systems: The new FNOMCeO recommendationsFNOMCeO presented a set of Recommendations for the use of social media, e-mail, and instant messaging in the medical setting and in physician-patient communication, to prevent the potential negative repercussions of improper use of these tools.
-
22DecArtificial intelligence and health care: News and issues in light of guidance from the Italian Data Protection Authority and the WHOThe use of AI in the healthcare field raises numerous issues. AI is promising and could facilitate improvement of treatment and prevention, and result in more effective allocation of resources in the field. However, there is trepidation about the consequences of possible errors and incorrect use.
-
14DecThe Lawyer European Awards 2023: Portolano Cavallo named European Litigation Team of the YearPortolano Cavallo was named “European Litigation Team of the Year” by the British magazine The Lawyer at its European Awards 2023.Article filed under: Dispute Resolution